Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597181 · ClinicalTrials.gov registry record · Phase 4
A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy
A Phase 4 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00597181 is a Phase 4 study that was terminated before completion, run by Indiana University. The registered enrollment target is 40 participants.
The verdict
NCT00597181, a Phase 4 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The less invasive nature of the Ex-Press Mini shunt with mitomycin C induces less post-operative inflammation than trabeculectomy with mitomycin c.
Interventions
- PROCEDURE Trabeculectomy with mitomycin c
- PROCEDURE Ex-Press mini shunt with mitomycin c
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00597181
The ClinicalTrials.gov registry entry for NCT00597181 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Trabeculectomy with mitomycin c is the first listed.
NCT00597181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00597181 about?
NCT00597181 is a clinical study titled "A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy". The less invasive nature of the Ex-Press Mini shunt with mitomycin C induces less post-operative inflammation than trabeculectomy with mitomycin c.
What is the current status of trial NCT00597181?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2007-11. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00597181?
The interventions under investigation include: Trabeculectomy with mitomycin c (PROCEDURE), Ex-Press mini shunt with mitomycin c (PROCEDURE).
Who is sponsoring clinical trial NCT00597181?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.